Experts has a new look! Let us know what you think of the updates.

Provide feedback

Home

Scholarly Works

Dual-Agent Molecular Targeting of the ErbB2...

Journal article

Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones

Authors

Hirte HW; Hotte SJ

Journal

Journal of Clinical Oncology, Vol. 26, No. 20, pp. 3301–3302

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

July 10, 2008

DOI

10.1200/jco.2008.16.3972

ISSN

0732-183X

Associated Experts

Holger Hirte

Professor Emeritus, Faculty of Health Sciences

Visit profile

Sebastien Hotte

Professor, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Dose-Response Relationship, Drug Drug Administration Schedule Drug Delivery Systems Female Humans Lapatinib Prognosis Quinazolines Receptor, ErbB-2 Survival Analysis Trastuzumab Treatment Outcome

View published work (Non-McMaster Users)

View published work (McMaster Users)